Glucotrack (GCTK) EBT Margin (2014 - 2020)
Glucotrack's (GCTK) quarterly EBT Margin came in at 629896.91% in Q2 2020, down 62908771.0% on a YoY basis from N/an in Q3 2019, and down 1711.37% quarter-over-quarter from 34774.61% in Q1 2020.
Powered by 
Analysis
Glucotrack (GCTK) EBT Margin (2014 - 2020) Analysis & Trends
Glucotrack (GCTK) has reported EBT Margin for 7 consecutive years, with 629896.91% the latest figure, recorded in Q2 2020.
- For the quarter ending Q2 2020, EBT Margin fell 62908771.0% year-over-year to 629896.91%; the trailing twelve-month figure through Sep 2020 stood at 5929.83% (up 725681.0% YoY), and the FY2019 full-year result was 1685.58%, up 1672099.0% from the prior year.
- EBT Margin retreated to 629896.91% in Q2 2020 per GCTK's latest filing, from 34774.61% in the prior quarter.
- Across five years, EBT Margin topped out at 9455.8% in Q4 2019 and bottomed at 629896.91% in Q2 2020.
- Historically, EBT Margin has averaged 45892.97% across 5 years, with a median of 1220.78% in 2016.
- The sharpest annual moves came in 2018 and 2020: EBT Margin surged 1724504 bps in 2018, then plunged 62908771 bps in 2020.
- Over 5 years, EBT Margin stood at 1020.51% in 2016, then surged by 490 bps to 3984.61% in 2017, then tumbled by 430 bps to 13130.81% in 2018, then surged by 172 bps to 9455.8% in 2019, then sank by 6761 bps to 629896.91% in 2020.
- According to Business Quant data, EBT Margin over the past three periods registered 629896.91%, 34774.61%, and 9455.8% for Q2 2020, Q1 2020, and Q4 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.91 Bn | 175.30 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.79 Bn | 122.57 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 116.85 Bn | 108.03 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 104.37 Bn | 100.89 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.81 Bn | 63.27 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.19 Bn | 30.25 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.67 Bn | 20.18 Bn | 684.20 Mn | 18.32% |
| 10 | Glucotrack | 1.07 Mn | -58,100.10 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -629,896.91% |
| Mar 31, 2020 | -34,774.61% |
| Dec 31, 2019 | 9,455.80% |
| Sep 30, 2019 | -23,484.38% |
| Jun 30, 2019 | -809.19% |
| Mar 31, 2019 | 4,010.07% |
| Jun 30, 2018 | -13,130.81% |
| Mar 31, 2018 | 6,781.61% |
| Dec 31, 2017 | 3,984.61% |
| Sep 30, 2017 | -12,699.00% |
| Jun 30, 2017 | -30,375.85% |
| Mar 31, 2017 | 2,707.19% |
| Dec 31, 2016 | -1,020.51% |
| Sep 30, 2016 | -13,198.04% |
| Jun 30, 2016 | -416.41% |
| Mar 31, 2016 | -1,421.05% |
| Jun 30, 2015 | -1,636.41% |
| Mar 31, 2015 | -1,164.90% |
| Dec 31, 2014 | -3,102.19% |
| Sep 30, 2014 | -3,041.82% |